SMS Lifesciences India Limited has received Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration for our API manufacturing facility (Unit 1) located at Kazipally, Telangana.

The receipt of EIR reaffirms the company's commitment to maintaining global quality standards and enables access to the regulated US market and other highly regulated global markets.